Editorial: Skin disinfection and bacterial contamination of blood components: Be simple

Transfusion

Volumn 50, Issue 1, 2010, Pages 5-8

  Bueno, Jose Luis ^a  

^a HOSPITAL NUESTRA SEÑORA DEL PRADO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APHERESIS; BACTERIUM CONTAMINATION; BLOOD COMPONENT; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CASE REPORT; EDITORIAL; HUMAN; KLEBSIELLA INFECTION; MALE; MORTALITY; SKIN DECONTAMINATION; THROMBOCYTE TRANSFUSION; BACTEREMIA; BLOOD COMPONENT THERAPY; DISEASE TRANSMISSION; DISINFECTION; METHODOLOGY; MICROBIOLOGY; NOTE; SKIN;

BACTEREMIA; BLOOD COMPONENT REMOVAL; BLOOD COMPONENT TRANSFUSION; DISINFECTION; HUMANS; SKIN;

EID: 73649086228     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02513.x     Document Type: Editorial

References (19)

1. Serious Hazard of Transfusion. The SHOT Report 2009 cited 2009 Aug 5]. Available from: http://www.shotuk.org/SHOT%20reports%20&%20Summaries.htm
2. Goldman M, Roy G, Frechette N, Decary F, Massicotte L, Delage G. Evaluation of donor skin disinfection methods. Transfusion 1997 37 : 309 12.
3. McDonald CP, Lowe P, Roy A, Robbins S, Hartley S, Harrison JF, Slopecki A, Verlander N, Barbara JA. Evaluation of donor arm disinfection techniques. Vox Sang 2001 80 : 135 41.
4. McDonald CP, Roy A, Mahajan P, Smith R, Charlett A, Barbara JA. Relative values of the interventions of diversion and improved donor-arm disinfection to reduce the bacterial risk from blood transfusion. Vox Sang 2004 86 : 178 82.
5. Liumbruno GM, Catalano L, Piccinini V, Pupella S, Grazzini G. Reduction of the risk of bacterial contamination of blood components through diversion of the first part of the donation of blood and blood components. Blood Transfus 2009 7 : 86 93.
6. Wagner SJ. Transfusion-transmitted bacterial infection: risks, sources and interventions. Vox Sang 2004 86 : 157 63.
7. de Korte D, Curvers J, de Kort WL, Hoekstra T, van der Poel CL, Beckers EA, Marcelis JH. Effects of skin disinfection method, deviation bag, and bacterial screening on clinical safety of platelet transfusions in the Netherlands. Transfusion 2006 46 : 476 85.
8. Benjamin RJ, Kline L, Dy BA, Kennedy J, Pisciotto P, Sapatnekar S, Mercado R, Eder AF. Bacterial contamination of whole-blood-derived platelets: the introduction of sample diversion and prestorage pooling with culture testing in the American Red Cross. Transfusion 2008 48 : 2348 55.
9. Eder AF, Kennedy JM, Dy BA, Notari EP, Skeate R, Bachowski G, Mair DC, Webb JS, Wagner SJ, Dodd RY, Benjamin RJ. Limiting and detecting bacterial contamination of apheresis platelets: inlet-line diversion and increased culture volume improve component safety. Transfusion 2009 49 : 1554 63.
10. Corash L. Pathogen reduction technology: methods, status of clinical trials, and future prospects. Curr Hematol Rep 2003 2 : 495 502.
11. Castro E, Bueno JL, Barea L, Gonzalez R. Feasibility of implementing an automated culture system for bacteria screening in platelets in the blood bank routine. Transfus Med 2005 15 : 185 95.
12. Eder AF, Kennedy JM, Dy BA, Notari EP, Weiss JW, Fang CT, Wagner S, Dodd RY, Benjamin RJ. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006). Transfusion 2007 47 : 1134 42.
13. Goldman MR. Should we attempt to detect bacteria in red blood cells? Transfusion 2008 48 : 1538 40.
14. Hundhausen T, Muller TH. False-positive alarms for bacterial screening of platelet concentrates with BacT/ALERT new-generation plastic bottles: a multicenter pilot study. Transfusion 2005 45 : 1267 74.
15. Vamvakas EC, Blajchman MA. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood 2009 113 : 3406 17.
16. AuBuchon JP. Pathogen reduction technologies: what are the concerns? Vox Sang 2004 87 Suppl 2 : 84 9.
17. Klein HG, Anderson D, Bernardi MJ, Cable R, Carey W, Hoch JS, Robitaille N, Sivilotti ML, Smaill F. Pathogen inactivation: making decisions about new technologies - preliminary report of a consensus conference. Vox Sang 2007 93 : 179 82. (Pubitemid 47228493)
18. Solheim BG. Pathogen reduction of blood components. Transfus Apher Sci 2008 39 : 75 82.
19. Solheim BG, Seghatchian J. The six questions of pathogen reduction technology: an overview of current opinions. Transfus Apher Sci 2008 39 : 51 7.